Our findings demonstrate the oncogenic role of METTL1 and the pathological significance of the METTL1-m⁷ G-EGFR/EFEMP1 axis in the BC development, thus providing potential therapeutic targets for the BC treatment.
No takes yet. Share an insight, caveat, or question.
Ying et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: